1. Home
  2. BME vs CTKB Comparison

BME vs CTKB Comparison

Compare BME & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock Health Sciences Trust

BME

Blackrock Health Sciences Trust

HOLD

Current Price

$39.87

Market Cap

511.9M

Sector

Finance

ML Signal

HOLD

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$3.86

Market Cap

541.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BME
CTKB
Founded
N/A
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
511.9M
541.1M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
BME
CTKB
Price
$39.87
$3.86
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$5.63
AVG Volume (30 Days)
44.3K
1.1M
Earning Date
01-01-0001
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$193,015,000.00
Revenue This Year
N/A
$5.42
Revenue Next Year
N/A
$7.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
17.67
52 Week Low
$35.03
$2.94
52 Week High
$42.74
$6.18

Technical Indicators

Market Signals
Indicator
BME
CTKB
Relative Strength Index (RSI) 49.06 42.06
Support Level $39.81 $3.71
Resistance Level $40.54 $4.49
Average True Range (ATR) 0.61 0.22
MACD -0.03 -0.01
Stochastic Oscillator 36.94 3.97

Price Performance

Historical Comparison
BME
CTKB

About BME Blackrock Health Sciences Trust

Blackrock Health Sciences Trust has an investment objective to provide total return and income mainly through long-term capital appreciation. The Trust invests the majority of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

Share on Social Networks: